IsoRay Inc.

(ISR)

By |

Profile

IsoRay Inc designs and develops personalized brachytherapy products. The company treats prostate cancer, brain, liver, breast cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer.

Contact Information

Website: www.isoray.com
Email: dbabcock@isoray.com
Main Phone: +1 509 375-5329
Address: 350 Hills Street
Address 2: Suite 106
State: WA
City / Town: Richland
Country: USA
Postal Code: 99354

Issuer Information

Exchange: AMX
CEO: Thomas C. Lavoy
Employees: 36
NAICS: Surgical and Medical Instrument Manufacturing (339112)
$ 0.46 $ -0.0149 (-3.17%)
Last Price 0.46 Change $ -0.0149 Change % -3.17 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.47 High 0.48 Low 0.45 Prev Close 0.47
Last Trade Volume 179,600 52 Wk Hi 0.65 52 Wk Low 0.36
Market Cap 25.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 55,100,229.00 EPS (TTM) -0.12 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 25
Number of Buys 0 25
Number of Sells 0 0
Net Activity 0 182075
Last 10 Buys Shares
Philip J. Vitale 1,000
Thomas C. Lavoy 1,000
Thomas C. Lavoy 1,000
Mark Austin 1,000
Mark Austin 1,000
Mark Austin 1,000
Mark Austin 1,000
Mark Austin 1,000
Mark Austin 1,000
Philip J. Vitale 1,000
Last 10 Sell Shares
William Cavanagh 1,000
Fredric Swindler 1,000
Fredric Swindler 1,000
William Cavanagh 1,000
Brien Ragle 1,000
Brien Ragle 1,000
Brien Ragle 1,000
Brien Ragle 1,000
Brien Ragle 1,000
Brien Ragle 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2 2 2 2
Low Target Price Estimate 1 1 1 1
Mean Target Price Estimate 1.5 1.5 1.5 1.5
Standard Deviation 0.71 0.71 0.71 0.71
Date of Most Recent Estimate 04/05/18 04/05/18 04/05/18 04/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.5 1